Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1861534rdf:typepubmed:Citationlld:pubmed
pubmed-article:1861534lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:1861534lifeskim:mentionsumls-concept:C0018183lld:lifeskim
pubmed-article:1861534lifeskim:mentionsumls-concept:C0026473lld:lifeskim
pubmed-article:1861534lifeskim:mentionsumls-concept:C1517806lld:lifeskim
pubmed-article:1861534lifeskim:mentionsumls-concept:C0439677lld:lifeskim
pubmed-article:1861534lifeskim:mentionsumls-concept:C1157216lld:lifeskim
pubmed-article:1861534lifeskim:mentionsumls-concept:C0449774lld:lifeskim
pubmed-article:1861534pubmed:issue6lld:pubmed
pubmed-article:1861534pubmed:dateCreated1991-9-4lld:pubmed
pubmed-article:1861534pubmed:abstractTextThe production of sulfated proteoglycans was compared in mature peripheral blood granulocytes and monocytes and HL-60 promyelocytic leukemia cells. We found that HL-60 cells synthesized 5-10 times more proteoglycans than peripheral blood leukocytes. Differentiation of HL-60 cells toward mature monocytes by treatment with 12-O-tetradecanoyl-phorbol-13-acetate (TPA) or towards granulocytes by treatment with retinoic acid or dibutyryl cyclic adenosine-3',5'-monophosphate (dbcAMP) resulted in a small (20-30%) decrease in sulfated proteoglycan biosynthesis. Chondroitin sulfate was found to be the predominant proteoglycan produced by monocytes, PMN and undifferentiated HL-60 cells. Differentiated HL-60 cells produced chondroitin sulfate as well as sulfated proteoglycans sensitive to nitrous acid degradation. Similar results were observed in TPA, dbcAMP and retinoic acid differentiated HL-60 cells indicating that the changes in proteoglycan biosynthesis observed were independent of the developmental pathway. Using specific monoclonal antibodies and flow cytometry, we also found that HL-60 cells and monocytes produced chondroitin-4-sulfate, chondroitin-6-sulfate and chondroitin-O-sulfate while PMN only produced chondroitin-4-sulfate. In addition, although there were no significant differences in antibody binding to undifferentiated and differentiated HL-60 cells, the tumor cells bound 5-20 times more of the antibodies than the peripheral blood leukocytes. Our data demonstrate that sulfated proteoglycan production by HL-60 cells is distinct from PMN and monocytes. In addition, the fact that differentiated HL-60 cells continue to synthesize larger amounts of the proteoglycans than the peripheral blood leukocytes indicates these cells have not completely matured.lld:pubmed
pubmed-article:1861534pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1861534pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1861534pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1861534pubmed:languageenglld:pubmed
pubmed-article:1861534pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1861534pubmed:citationSubsetIMlld:pubmed
pubmed-article:1861534pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1861534pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1861534pubmed:statusMEDLINElld:pubmed
pubmed-article:1861534pubmed:issn0145-2126lld:pubmed
pubmed-article:1861534pubmed:authorpubmed-author:LaskinJ DJDlld:pubmed
pubmed-article:1861534pubmed:authorpubmed-author:LaskinD LDLlld:pubmed
pubmed-article:1861534pubmed:authorpubmed-author:SirakA AAAlld:pubmed
pubmed-article:1861534pubmed:authorpubmed-author:DokidisAAlld:pubmed
pubmed-article:1861534pubmed:issnTypePrintlld:pubmed
pubmed-article:1861534pubmed:volume15lld:pubmed
pubmed-article:1861534pubmed:ownerNLMlld:pubmed
pubmed-article:1861534pubmed:authorsCompleteYlld:pubmed
pubmed-article:1861534pubmed:pagination515-23lld:pubmed
pubmed-article:1861534pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:1861534pubmed:meshHeadingpubmed-meshheading:1861534-...lld:pubmed
pubmed-article:1861534pubmed:meshHeadingpubmed-meshheading:1861534-...lld:pubmed
pubmed-article:1861534pubmed:meshHeadingpubmed-meshheading:1861534-...lld:pubmed
pubmed-article:1861534pubmed:meshHeadingpubmed-meshheading:1861534-...lld:pubmed
pubmed-article:1861534pubmed:meshHeadingpubmed-meshheading:1861534-...lld:pubmed
pubmed-article:1861534pubmed:meshHeadingpubmed-meshheading:1861534-...lld:pubmed
pubmed-article:1861534pubmed:meshHeadingpubmed-meshheading:1861534-...lld:pubmed
pubmed-article:1861534pubmed:meshHeadingpubmed-meshheading:1861534-...lld:pubmed
pubmed-article:1861534pubmed:meshHeadingpubmed-meshheading:1861534-...lld:pubmed
pubmed-article:1861534pubmed:meshHeadingpubmed-meshheading:1861534-...lld:pubmed
pubmed-article:1861534pubmed:meshHeadingpubmed-meshheading:1861534-...lld:pubmed
pubmed-article:1861534pubmed:year1991lld:pubmed
pubmed-article:1861534pubmed:articleTitleDistinct patterns of sulfated proteoglycan biosynthesis in human monocytes, granulocytes and myeloid leukemic cells.lld:pubmed
pubmed-article:1861534pubmed:affiliationDepartment of Environmental and Community Medicine, UMDNJ-Robert Wood Johnson Medical School, Rutgers University, Piscataway 08854.lld:pubmed
pubmed-article:1861534pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1861534pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:1861534pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1861534lld:pubmed